{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T13:30:29Z","timestamp":1789047029669,"version":"build-2803163510"},"reference-count":169,"publisher":"American Society for Microbiology","issue":"3","license":[{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1128\/ASMCopyrightv2"},{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"DOI":"10.13039\/501100020643","name":"Medical Research Centre","doi-asserted-by":"publisher","award":["2928808"],"award-info":[{"award-number":["2928808"]}],"id":[{"id":"10.13039\/501100020643","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Clin Microbiol Rev"],"published-print":{"date-parts":[[2026,9,10]]},"abstract":"<jats:title>SUMMARY<\/jats:title>\n                  <jats:p>Urinary tract infections (UTIs) are among the most common bacterial infections worldwide, with catheter-associated UTIs (CAUTIs) representing a major subset in healthcare settings. CAUTIs significantly increase patient morbidity, mortality, hospital stays, and healthcare costs, while driving antibiotic overuse and antimicrobial resistance (AMR). Systemic antibiotics often fail due to poor biofilm penetration, localized infection sites, and rising multidrug resistance, highlighting the urgent need for alternative, targeted therapies. This review discusses the role of intravesical therapies in both the treatment and prevention of CAUTIs, with a primary emphasis on therapeutic applications. The bladder is an accessible target for local treatment, as catheters can be repurposed for drug delivery. These devices are frequently colonized by biofilm-forming bacteria that contribute to persistent infection and treatment failure. This review explores intravesical therapy, the direct instillation of antimicrobial agents into the bladder, as a promising strategy to improve CAUTI management and mitigate AMR. We examine CAUTI pathogenesis, biofilm development, and current clinical approaches, including antimicrobial stewardship, catheter management, and coating technologies. Evidence for intravesical antibiotics such as gentamicin, amikacin, colistin, fosfomycin, and trimethoprim is reviewed alongside limited data from clinical trials, and applications in other urological disorders. Non-antibiotic alternatives, including sterile saline, antiseptic solutions, bacteriophages, antimicrobial peptides, natural bioactives, probiotics, and silver nanoparticles, are also discussed, particularly for their potential synergistic use with antibiotics to reduce resistance emergence. Despite encouraging results, intravesical therapy faces challenges such as limited clinical data, lack of standardized protocols, and delivery barriers. This review summarizes current evidence, identifies research gaps, and proposes directions to advance this underused strategy against CAUTIs amid escalating antibiotic resistance.<\/jats:p>","DOI":"10.1128\/cmr.00382-25","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T13:00:19Z","timestamp":1781701219000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":1,"title":["Intravesical therapies for catheter-associated urinary tract infections: current approaches and future directions"],"prefix":"10.1128","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-0384-7511","authenticated-orcid":false,"given":"Chloe","family":"Linham","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/026k5mg93","id-type":"ROR","asserted-by":"publisher"}],"name":"School of Chemistry, Pharmacy and Pharmacology, University of East Anglia","place":["Norwich, United Kingdom"]},{"id":[{"id":"https:\/\/ror.org\/0062dz060","id-type":"ROR","asserted-by":"publisher"}],"name":"Quadram Institute, Norwich Research Park","place":["Norwich, United Kingdom"]},{"id":[{"id":"https:\/\/ror.org\/0062dz060","id-type":"ROR","asserted-by":"publisher"}],"name":"Centre for Microbial Interactions, Norwich Research Park","place":["Norwich, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9169-7592","authenticated-orcid":true,"given":"Mark","family":"Webber","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/0062dz060","id-type":"ROR","asserted-by":"publisher"}],"name":"Quadram Institute, Norwich Research Park","place":["Norwich, United Kingdom"]},{"id":[{"id":"https:\/\/ror.org\/0062dz060","id-type":"ROR","asserted-by":"publisher"}],"name":"Centre for Microbial Interactions, Norwich Research Park","place":["Norwich, United Kingdom"]},{"id":[{"id":"https:\/\/ror.org\/026k5mg93","id-type":"ROR","asserted-by":"publisher"}],"name":"Norwich Medical School, University of East Anglia","place":["Norwich, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1872-9572","authenticated-orcid":true,"given":"Sheng","family":"Qi","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/026k5mg93","id-type":"ROR","asserted-by":"publisher"}],"name":"School of Chemistry, Pharmacy and Pharmacology, University of East Anglia","place":["Norwich, United Kingdom"]},{"id":[{"id":"https:\/\/ror.org\/0062dz060","id-type":"ROR","asserted-by":"publisher"}],"name":"Centre for Microbial Interactions, Norwich Research Park","place":["Norwich, United Kingdom"]},{"id":[{"id":"https:\/\/ror.org\/04xs57h96","id-type":"ROR","asserted-by":"publisher"}],"name":"School of Pharmacy and Pharmaceutical Sciences, Institute of Systems, Molecular and Integrative Biology, University of Liverpool","place":["Liverpool, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1086\/318850"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1047-2797(00)00072-7"},{"key":"e_1_3_2_4_2","unstructured":"Better Health Channel. 2022. Urinary tract infections (UTI). Available from: https:\/\/www.betterhealth.vic.gov.au\/health\/conditionsandtreatments\/urinary-tract-infections-uti. Retrieved 20 Apr 2026."},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrurol.2010.101"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro3432"},{"key":"e_1_3_2_7_2","unstructured":"Centers for Disease Control and Prevention (CDC). 2025. Catheter-associated urinary tract infection (CAUTI) basics. Available from: https:\/\/www.cdc.gov\/uti\/about\/cauti-basics.html. Retrieved 20 Apr 2026."},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhin.2020.09.030"},{"key":"e_1_3_2_9_2","unstructured":"North Bristol NHS Trust Urology Department. 2023. Guidance for GPS on intravesical gentamicin and amikacin. Available from: https:\/\/remedy.bnssg.icb.nhs.uk\/media\/vllbrlj5\/guidance-for-gps-on-intravesical-gentamicin-and-amikacin-vs3.pdf. Retrieved 20 Apr 2026."},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.12968\/bjon.2011.20.9.564"},{"key":"e_1_3_2_11_2","unstructured":"UroToday. 2026. Complications of indwelling urinary catheters. Available from: https:\/\/www.urotoday.com\/urinary-catheters-home\/indwelling-catheters\/complications\/problems.html. Retrieved 20 Apr 2026."},{"key":"e_1_3_2_12_2","unstructured":"Centers for Disease Control and Prevention (CDC). 2024. Catheter-associated urinary tract infections (CAUTI) prevention. Available from: https:\/\/www.cdc.gov\/infection-control\/hcp\/cauti\/index.html. Retrieved 20 Apr 2026."},{"key":"e_1_3_2_13_2","volume-title":"Asymptomatic bacteriuria","author":"Givler DN","year":"2023","unstructured":"Givler DN, Givler A. 2023. Asymptomatic bacteriuria. StatPearls, National Center for Biotechnology Information (NCBI) Bookshelf. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK441848\/."},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens12040623"},{"key":"e_1_3_2_15_2","volume-title":"Escherichia coli infection","author":"Mueller M","year":"2025","unstructured":"Mueller M, Rausch-Phung EA, Tainter CR. 2025. Escherichia coli infection. StatPearls. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK564298\/."},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1310\/sci2503-228"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.3390\/genes13081397"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/jam.13078"},{"key":"e_1_3_2_19_2","unstructured":"Barker H. 2023. Infographic: stages of biofilm formation."},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.15190\/d.2019.13"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioflm.2020.100027"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajic.2003.08.005"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.15.2.155-166.2002"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0602136103"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.copbio.2019.10.009"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eursup.2016.04.003"},{"key":"e_1_3_2_27_2","unstructured":"Oxford Languages. 2025. Oxford Languages. Available from: https:\/\/languages.oup.com\/google-dictionary-en"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2021.10.020"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-022-00820-y"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2019.02.007"},{"key":"e_1_3_2_31_2","unstructured":"National Institute for Health and Care Excellence (NICE). 2018. Urinary tract infection (lower): antimicrobial prescribing (NG109). Available from: https:\/\/www.nice.org.uk\/guidance\/ng109. Retrieved 20 Apr 2026."},{"key":"e_1_3_2_32_2","unstructured":"National Institute for Health and Care Excellence. 2018. Pyelonephritis (acute): antimicrobial prescribing (NG111). Available from: https:\/\/www.nice.org.uk\/guidance\/ng111. Retrieved 20 Apr 2026."},{"key":"e_1_3_2_33_2","unstructured":"National Institute for Health and Care Excellence (NICE). 2018. Urinary tract infection (catheter-associated): antimicrobial prescribing (NG113). Available from: https:\/\/www.nice.org.uk\/guidance\/ng113. Retrieved 20 Apr 2026."},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkad082"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.medmic.2024.100106"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.5489\/cuaj.4434"},{"key":"e_1_3_2_37_2","unstructured":"National Institute for Health and Care Excellence (NICE). 2026. Antimicrobial stewardship. Available from: https:\/\/bnf.nice.org.uk\/medicines-guidance\/antimicrobial-stewardship. Retrieved 20 Apr 2026."},{"key":"e_1_3_2_38_2","unstructured":"Centers for Disease Control and Prevention. 2024. Catheter-associated urinary tract infections (CAUTI) basics. Available from: https:\/\/www.cdc.gov\/uti\/about\/cauti-basics.html. Retrieved 20 Apr 2026."},{"key":"e_1_3_2_39_2","unstructured":"UK Health Security Agency. 2023. Start smart then focus: antimicrobial stewardship toolkit for inpatient care settings. Available from: https:\/\/www.gov.uk\/government\/publications\/antimicrobial-stewardship-start-smart-then-focus\/start-smart-then-focus-antimicrobial-stewardship-toolkit-for-inpatient-care-settings. Retrieved 20 Apr 2026."},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhin.2020.09.010"},{"key":"e_1_3_2_41_2","unstructured":"Healthcare Infection Control Practices Advisory Committee (HICPAC). 2016. Antibiotic stewardship statement for antibiotic guidelines. Available from: https:\/\/www.cdc.gov\/hicpac\/media\/pdfs\/antibiotic-stewardship-statement-508.pdf. Retrieved 20 Apr 2026."},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1186\/cc8219"},{"key":"e_1_3_2_43_2","unstructured":"National Institute for Health and Care Excellence (NICE). 2018. Urinary tract infection (catheter-associated): antimicrobial prescribing (NG113) \u2014 evidence."},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-023-08475-7"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcjq.2020.08.015"},{"key":"e_1_3_2_46_2","unstructured":"Agency for Healthcare Research and Quality. 2017. Guide to implementing a program to reduce catheter-associated urinary tract infections in long-term care. Available from: https:\/\/www.ahrq.gov\/hai\/quality\/tools\/cauti-ltc\/modules\/implementation\/guide.html. Retrieved 20 Apr 2026."},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1002\/nop2.1384"},{"key":"e_1_3_2_48_2","unstructured":"Mayo Clinic Health System. 2022. 5 tips to prevent a urinary tract infection. Available from: https:\/\/www.mayoclinichealthsystem.org\/hometown-health\/speaking-of-health\/5-tips-to-prevent-a-urinary-tract-infection. Retrieved 20 Apr 2026."},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhin.2023.11.005"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10102580"},{"key":"e_1_3_2_51_2","unstructured":"Bueno Technology. 2024. Ptfe (teflon) technical specification. Available from: https:\/\/www.buenoeco.com\/ptfe-technical-specification. Retrieved 20 Apr 2026."},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.actbio.2016.11.070"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20041001"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1021\/acsabm.8b00100"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.2147\/RRU.S273663"},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1134433"},{"key":"e_1_3_2_57_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2672.2012.05253.x"},{"key":"e_1_3_2_58_2","unstructured":"DrugBank. 2026. Silver (DB12965). Available from: https:\/\/go.drugbank.com\/drugs\/DB12965. Retrieved 20 Apr 2026."},{"key":"e_1_3_2_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(98)00240-X"},{"key":"e_1_3_2_60_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61380-4"},{"key":"e_1_3_2_61_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jointm.2023.06.003"},{"key":"e_1_3_2_62_2","unstructured":"National Center for Biotechnology Information. 2026. Nitrofurazone (CID: 5447130). Available from: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Nitrofurazone. Retrieved 20 Apr 2026."},{"key":"e_1_3_2_63_2","unstructured":"DrugBank. 2026. Nitrofural (DB00336). Available from: https:\/\/go.drugbank.com\/drugs\/DB00336. Retrieved 20 Apr 2026."},{"key":"e_1_3_2_64_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2010.07.036"},{"key":"e_1_3_2_65_2","unstructured":"Camstent Ltd. 2026. Camstent technology: bacteriaphobic coating for medical devices. Available from: https:\/\/www.camstent.com\/technology. Retrieved 20 Apr 2026."},{"key":"e_1_3_2_66_2","doi-asserted-by":"crossref","unstructured":"University of Nottingham. 2023. The University of Nottingham and angel guard set to revolutionise the world of plastics through new polymer launch. Available from: https:\/\/www.nottingham.ac.uk\/news\/the-university-of-nottingham-and-angel-guard-set-to-revolutionise-the-world-of-plastics-through-new-polymer-launch. Retrieved 20 Apr 2026.","DOI":"10.12968\/S0306-3747(23)70148-6"},{"key":"e_1_3_2_67_2","unstructured":"Royal Berkshire NHS Foundation Trust. 2024. Intravesical gentamicin treatment for urinary tract infections. Patient information leaflet."},{"key":"e_1_3_2_68_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11934-018-0834-8"},{"key":"e_1_3_2_69_2","doi-asserted-by":"publisher","DOI":"10.3978\/j.issn.2223-4683.2015.10.07"},{"key":"e_1_3_2_70_2","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens12030417"},{"key":"e_1_3_2_71_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2025.02.010"},{"key":"e_1_3_2_72_2","doi-asserted-by":"publisher","DOI":"10.2147\/ITT.S202006"},{"key":"e_1_3_2_73_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00192-012-1802-3"},{"key":"e_1_3_2_74_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2009.01.117"},{"key":"e_1_3_2_75_2","doi-asserted-by":"publisher","DOI":"10.1590\/S1677-5538.IBJU.2015.0588"},{"key":"e_1_3_2_76_2","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11101335"},{"key":"e_1_3_2_77_2","unstructured":"Alder Hey Children\u2019s NHS Foundation Trust. 2025. Bladder instillation of gentamicin. Available from: https:\/\/www.alderhey.nhs.uk\/conditions\/patient-information-leaflets\/bladder-instillation-of-gentamicin. Retrieved 20 Apr 2026."},{"key":"e_1_3_2_78_2","unstructured":"University Hospitals Bristol and Weston NHS Foundation Trust. 2023. Intravesical gentamicin clinical guideline. Available from: https:\/\/www.uhbw.nhs.uk\/assets\/1\/24-249_intravesical_gentamicin_clinical_guideline_aug_23_redacted.pdf. Retrieved 20 Apr 2026."},{"key":"e_1_3_2_79_2","unstructured":"University Hospitals of Leicester NHS Trust Urology Department. 2024. Management of recurrent urinary tract infections in adult patients within the urology department (UHL chuggs guideline)."},{"key":"e_1_3_2_80_2","unstructured":"Royal Devon and Exeter NHS Foundation Trust. 2011. Intravesical gentamicin protocol. Available from: https:\/\/www.yumpu.com\/en\/document\/view\/47675399\/intravesical-gentamicin-protocol-royal-devon-exeter-hospital. Retrieved 20 Apr 2026."},{"key":"e_1_3_2_81_2","unstructured":"DrugBank. 2026. Gentamicin (DB00798). Available from: https:\/\/go.drugbank.com\/drugs\/DB00798. Retrieved 20 Apr 2026."},{"key":"e_1_3_2_82_2","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a027029"},{"key":"e_1_3_2_83_2","unstructured":"National Center for Biotechnology Information (NCBI). 2026. Pubchem compound summary for gentamicin (CID 3467). Available from: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Gentamicin. Retrieved 20 Apr 2026."},{"key":"e_1_3_2_84_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.43.5.1003"},{"key":"e_1_3_2_85_2","unstructured":"StatPearls Publishing. 2026. Nephrotoxicity and ototoxicity of aminoglycosides. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK557550\/. Retrieved 20 Apr 2026."},{"key":"e_1_3_2_86_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpurol.2020.08.007"},{"key":"e_1_3_2_87_2","doi-asserted-by":"publisher","DOI":"10.1002\/nau.70037"},{"key":"e_1_3_2_88_2","unstructured":"Drugs.com. 2026. Gentamicin side effects. Available from: https:\/\/www.drugs.com\/sfx\/gentamicin-side-effects.html. Retrieved 20 Apr 2026."},{"key":"e_1_3_2_89_2","unstructured":"DrugBank. 2026. Amikacin (DB00479). Available from: https:\/\/go.drugbank.com\/drugs\/DB00479. Retrieved 20 Apr 2026."},{"key":"e_1_3_2_90_2","doi-asserted-by":"publisher","DOI":"10.1080\/10790268.2021.1922832"},{"key":"e_1_3_2_91_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365548.2012.737018"},{"key":"e_1_3_2_92_2","unstructured":"StatPearls Publishing. 2026. Chlorhexidine. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK557540\/. Retrieved 20 Apr 2026."},{"key":"e_1_3_2_93_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(14)70850-3"},{"key":"e_1_3_2_94_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00064-16"},{"key":"e_1_3_2_95_2","doi-asserted-by":"publisher","DOI":"10.1186\/1752-1947-6-426"},{"key":"e_1_3_2_96_2","doi-asserted-by":"publisher","DOI":"10.12890\/2019_000996"},{"key":"e_1_3_2_97_2","unstructured":"DrugBank. 2026. Fosfomycin (DB00828). Available from: https:\/\/go.drugbank.com\/drugs\/DB00828. Retrieved 20 Apr 2026."},{"key":"e_1_3_2_98_2","doi-asserted-by":"publisher","DOI":"10.5489\/cuaj.7365"},{"key":"e_1_3_2_99_2","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S32733"},{"key":"e_1_3_2_100_2","unstructured":"DrugBank. 2026. Trimethoprim (DB00440). Available from: https:\/\/go.drugbank.com\/drugs\/DB00440. Retrieved 20 Apr 2026."},{"key":"e_1_3_2_101_2","doi-asserted-by":"publisher","DOI":"10.1159\/000237760"},{"key":"e_1_3_2_102_2","doi-asserted-by":"publisher","DOI":"10.1021\/acsomega.0c01745"},{"key":"e_1_3_2_103_2","doi-asserted-by":"publisher","DOI":"10.1111\/bju.16552"},{"key":"e_1_3_2_104_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajic.2018.05.009"},{"key":"e_1_3_2_105_2","doi-asserted-by":"publisher","DOI":"10.1080\/10790268.2006.11753877"},{"key":"e_1_3_2_106_2","unstructured":"DermNet New Zealand Trust. 2023. Antiseptics. Available from: https:\/\/dermnetnz.org\/topics\/antiseptic. Retrieved 20 Apr 2026."},{"key":"e_1_3_2_107_2","unstructured":"DrugBank. 2026. Chlorhexidine (DB00878). Available from: https:\/\/go.drugbank.com\/drugs\/DB00878. Retrieved 20 Apr 2026."},{"key":"e_1_3_2_108_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)43237-X"},{"key":"e_1_3_2_109_2","doi-asserted-by":"publisher","DOI":"10.2340\/16501977-2298"},{"key":"e_1_3_2_110_2","unstructured":"DrugBank. 2026. Povidone-Iodine (DB06812). Available from: https:\/\/go.drugbank.com\/drugs\/DB06812. Retrieved 20 Apr 2026."},{"key":"e_1_3_2_111_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-60522-4"},{"key":"e_1_3_2_112_2","doi-asserted-by":"publisher","DOI":"10.1002\/nau.24607"},{"key":"e_1_3_2_113_2","unstructured":"DrugBank. 2026. Methenamine (DB06799). Available from: https:\/\/go.drugbank.com\/drugs\/DB06799. Retrieved 20 Apr 2026."},{"key":"e_1_3_2_114_2","unstructured":"National Institute for Health and Care Research (NIHR). 2022. Methenamine as good as antibiotics for preventing urinary tract infections. Available from: https:\/\/evidence.nihr.ac.uk\/alert\/methenamine-as-good-as-antibiotics-preventing-urinary-tract-infections\/. Retrieved 20 Apr 2026."},{"key":"e_1_3_2_115_2","volume-title":"Bacteriophages","author":"Kasman LM","year":"2022","unstructured":"Kasman LM, Porter LD. 2022. Bacteriophages. StatPearls, Treasure Island (FL). https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK493185\/."},{"key":"e_1_3_2_116_2","doi-asserted-by":"publisher","DOI":"10.1089\/phage.2023.0024"},{"key":"e_1_3_2_117_2","doi-asserted-by":"publisher","DOI":"10.1128\/ecosalplus.esp-0029-2023"},{"key":"e_1_3_2_118_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.582779"},{"key":"e_1_3_2_119_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25094870"},{"key":"e_1_3_2_120_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1302005"},{"key":"e_1_3_2_121_2","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics10060650"},{"key":"e_1_3_2_122_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001322"},{"key":"e_1_3_2_123_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001321.pub6"},{"key":"e_1_3_2_124_2","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6882-14-499"},{"key":"e_1_3_2_125_2","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2024.1422121"},{"key":"e_1_3_2_126_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12937-022-00769-x"},{"key":"e_1_3_2_127_2","unstructured":"National Cancer Institute (NCI) PDQ Integrative Alternative and Complementary Therapies Editorial Board. 2025. Curcumin (curcuma turmeric) and cancer (PDQ)\u2013health professional version. Available from: https:\/\/www.cancer.gov\/about-cancer\/treatment\/cam\/hp\/curcumin-pdq. Retrieved 20 Apr 2026."},{"key":"e_1_3_2_128_2","unstructured":"FoundMyFitness. 2017. Curcumin may act as an intervention in chronic urinary tract infection through dampening of toll-like receptors and reducing bacterial colony count. Available from: https:\/\/www.foundmyfitness.com\/news\/s\/fbkw77\/curcumin_may_act_as_an_intervention_in_chronic_urinary_tract_infection_through_dampening_of_toll-like_receptors_and_reducing_bacterial_colony_count. Retrieved 20 Apr 2026."},{"key":"e_1_3_2_129_2","doi-asserted-by":"publisher","DOI":"10.1002\/cbdv.202000171"},{"key":"e_1_3_2_130_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.apjtm.2017.06.009"},{"key":"e_1_3_2_131_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008772.pub2"},{"key":"e_1_3_2_132_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir183"},{"key":"e_1_3_2_133_2","doi-asserted-by":"publisher","DOI":"10.1177\/1756287219875594"},{"key":"e_1_3_2_134_2","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.656496"},{"key":"e_1_3_2_135_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1072043"},{"key":"e_1_3_2_136_2","doi-asserted-by":"publisher","DOI":"10.1049\/iet-nbt.2018.5415"},{"key":"e_1_3_2_137_2","unstructured":"UK Health Security Agency. 2024. Acetic acid: general information. Available from: https:\/\/www.gov.uk\/government\/publications\/acetic-acid-properties-uses-and-incident-management\/acetic-acid-general-information. Retrieved 20 Apr 2026."},{"key":"e_1_3_2_138_2","unstructured":"Cleveland Clinic. 2026. Acetic acid bladder irrigation. Available from: https:\/\/my.clevelandclinic.org\/health\/drugs\/18474-acetic-acid-irrigation-solution. Retrieved 20 Apr 2026."},{"key":"e_1_3_2_139_2","unstructured":"Paediatric Surgical Associates. 2021. Vinegar bladder irrigation protocol. Available from: https:\/\/www.pediatricsurgical.com\/wp-content\/uploads\/2021\/03\/Vinegar-Bladder-Irrigation-Protocol.pdf. Retrieved 20 Apr 2026."},{"key":"e_1_3_2_140_2","unstructured":"Pfizer Inc. Prescribing information (labeling). Available from: https:\/\/labeling.pfizer.com\/ShowLabeling.aspx?id=4100. Retrieved 22 Apr 2026."},{"key":"e_1_3_2_141_2","doi-asserted-by":"publisher","DOI":"10.3109\/inf.1978.10.issue-1.16"},{"key":"e_1_3_2_142_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410x.1989.tb06049.x"},{"key":"e_1_3_2_143_2","unstructured":"International Continence Society. 2024. Effectiveness and safety of intravesical gentamicin for recurrent urinary tract infection (abstract 602). Available from: https:\/\/www.ics.org\/2024\/abstract\/602. Retrieved 20 Apr 2026."},{"key":"e_1_3_2_144_2","unstructured":"Medical News Today. 2018. What is the normal urine pH level? Available from: https:\/\/www.medicalnewstoday.com\/articles\/323957. Retrieved 20 Apr 2026."},{"key":"e_1_3_2_145_2","doi-asserted-by":"publisher","DOI":"10.1308\/003588413X13629960046165"},{"key":"e_1_3_2_146_2","doi-asserted-by":"publisher","DOI":"10.1159\/000279080"},{"key":"e_1_3_2_147_2","unstructured":"IBSA Farmaceutici Italia \/ IAluRil. 2024. Ialuril dosage and administration (patient information). Available from: https:\/\/ialuril.co.uk\/dosage-and-administration-patient. Retrieved 20 Apr 2026."},{"key":"e_1_3_2_148_2","unstructured":"IBSA Farmaceutici Italia \/ IAluRil. 2026. Ialuril Hcp product information. Available from: https:\/\/ialuril.co.uk\/hcp-home\/product-info. Retrieved 20 Apr 2026."},{"key":"e_1_3_2_149_2","unstructured":"Noah A Joshi D Palanivel S Vincencio M Macrae B. 2023. Intravesical gentamicin for recurrent urinary tract infections (adults). UCLH Urology and infection division University College of London Hospitals (UCLH) NHS trust wide guideline."},{"key":"e_1_3_2_150_2","unstructured":"Broadwith P. 2025. Ignoring women\u2019s health shouldn\u2019t be an option. Chemistry World. Available from: https:\/\/www.chemistryworld.com\/opinion\/ignoring-womens-health-shouldnt-be-an-option\/4021559.article. Retrieved 20 Apr 2026."},{"key":"e_1_3_2_151_2","unstructured":"Ritter G. 2023. Pharma governance and the quest for gender equity. Available from: https:\/\/www.pharmexec.com\/view\/pharma-governance-and-the-quest-for-gender-equity. Retrieved 20 Apr 2026."},{"key":"e_1_3_2_152_2","unstructured":"Simmons A. 2024. Closing the sex and gender gap in medical research. Medical Research Foundation. Available from: https:\/\/www.medicalresearchfoundation.org.uk\/news\/closing-the-sex-and-gender-gap-in-medical-research. Retrieved 20 Apr 2026."},{"key":"e_1_3_2_153_2","volume-title":"Drug-related cystitis: an overview","author":"Engin S","year":"2023","unstructured":"Engin S. 2023. IntechOpen chapter. In Drug-related cystitis: an overview"},{"key":"e_1_3_2_154_2","first-page":"33","volume-title":"Nonclinical considerations: disposition of drugs","author":"Green MD","year":"1993","unstructured":"Green MD. 1993. Nonclinical considerations: disposition of drugs, p 33\u201337. Springer eBooks."},{"key":"e_1_3_2_155_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2018.2417"},{"key":"e_1_3_2_156_2","unstructured":"Interstitial Cystitis Association. 2025. Bladder instillations. Available from: https:\/\/www.ichelp.org\/understanding-ic\/medical-treatments\/bladder-instillations\/. Retrieved 20 Apr 2026."},{"key":"e_1_3_2_157_2","doi-asserted-by":"publisher","DOI":"10.5213\/inj.2040108.054"},{"key":"e_1_3_2_158_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-025-10609-w"},{"key":"e_1_3_2_159_2","doi-asserted-by":"publisher","DOI":"10.3390\/nano13030555"},{"key":"e_1_3_2_160_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2023.102685"},{"key":"e_1_3_2_161_2","doi-asserted-by":"publisher","DOI":"10.1111\/iju.13317"},{"key":"e_1_3_2_162_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2009.06.024"},{"key":"e_1_3_2_163_2","doi-asserted-by":"publisher","DOI":"10.1002\/mba2.100"},{"key":"e_1_3_2_164_2","doi-asserted-by":"publisher","DOI":"10.2166\/wst.2015.567"},{"key":"e_1_3_2_165_2","doi-asserted-by":"publisher","DOI":"10.1039\/d3tb00148b"},{"key":"e_1_3_2_166_2","doi-asserted-by":"publisher","DOI":"10.3390\/polym17040518"},{"key":"e_1_3_2_167_2","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00218-20"},{"key":"e_1_3_2_168_2","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.70414"},{"key":"e_1_3_2_169_2","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1134433"},{"key":"e_1_3_2_170_2","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics14060545"}],"container-title":["Clinical Microbiology Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/cmr.00382-25","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/cmr.00382-25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T13:03:21Z","timestamp":1789045401000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/cmr.00382-25"}},"subtitle":[],"editor":[{"given":"Jacinda","family":"Abdul-Mutakabbir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":169,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9,10]]}},"alternative-id":["10.1128\/cmr.00382-25"],"URL":"https:\/\/doi.org\/10.1128\/cmr.00382-25","relation":{},"ISSN":["0893-8512","1098-6618"],"issn-type":[{"value":"0893-8512","type":"print"},{"value":"1098-6618","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,10]]},"assertion":[{"value":"2026-06-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e00382-25"}}